Surgery – Means for introducing or removing material from body for... – Treating material introduced into or removed from body...
Reexamination Certificate
2006-06-03
2011-10-18
Lucchesi, Nicholas D (Department: 3763)
Surgery
Means for introducing or removing material from body for...
Treating material introduced into or removed from body...
Reexamination Certificate
active
08038645
ABSTRACT:
The invention relates to a device for the time-controlled intravenous administering of the anesthetic propofol by means of a method used for determining an adequate dosage profile and adequately controlling an infusion pump as a metering apparatus.
REFERENCES:
patent: 5609575 (1997-03-01), Larson et al.
patent: 5687208 (1997-11-01), Bae et al.
patent: 5775330 (1998-07-01), Kangas et al.
patent: 5870697 (1999-02-01), Chandler et al.
patent: 6016444 (2000-01-01), John
patent: 7765092 (2010-07-01), Schmitt et al.
patent: 2004/0172230 (2004-09-01), Willmann et al.
patent: 2004/0172330 (2004-09-01), Willmann et al.
patent: 2004/0236554 (2004-11-01), Raghavan et al.
patent: 2005/0074803 (2005-04-01), Schmitt et al.
patent: 2005/0075274 (2005-04-01), Willmann et al.
patent: 2005/0119832 (2005-06-01), Schmitt et al.
patent: 2007/0015972 (2007-01-01), Wang et al.
patent: 2007/0196479 (2007-08-01), Willmann et al.
patent: 2007/0196497 (2007-08-01), Pouliquen et al.
patent: 2007/0253903 (2007-11-01), Knab et al.
patent: 2009/0306944 (2009-12-01), Willmann et al.
patent: 10160270 (2003-06-01), None
patent: 10345836 (2005-04-01), None
patent: 10345837 (2005-04-01), None
patent: 102004010516 (2005-09-01), None
patent: 1479403 (2004-04-01), None
patent: 2005075274 (2005-08-01), None
patent: 2005084731 (2005-09-01), None
Munoz H. R., Cortinez L I., Ibacache M. E., Altmann C., Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect. Anesthesiology 2004; 101:1269-74.
Gepts E. Camu F., Cockshott I. D., Douglas E. J. Disposition of propofol administered as constant rate intravenous infusions in humans, Anesth Analg 1987, 66(12):1256-63.
Kazama T., Ikeda K., Morita K, Kikura M., Ikeda T., Kurita T. et al, Investigation of effective anesthesia induction doses using a wide range of infusion rates with undiluted and diluted propofol. Anesthesiology 2000, 92(4):1017-28.
Wintermark M., Lepori D., Cotting J., Roulet E., van M. G., Meuli R. et al., Brain perfusion in children: evolution with age assessed by quantitative perfusion computed tomography. Pediatrics 2004; 113(6):1642-52.
Servin F., Farinotti R., Haberer J., Desmonts J., Propofol infusion for maintenance of anesthesia in morbidly obese patients receiving nitrous oxide. Anesthesiology 2005, 78:657-65.
Rigby-Jones A. E., Nolan J. A., Priston M. J., Wright P., Sneyd R., Wolf A. R., Pharacokinetics of propofol infusions in critically ill neonates, infants, and children in an intensive care unit. Antesthesiology 2002, 97:1393-400.
Levitt D. G., Schnider T. W., Human physiologically based pharmacokinetic model for propofol. BMC Anesthesiol. 22. Apr. 2005, 5(1):4.
P. S. Price, R. B. Conolly, C. F. Chaisson, E. A. Gross, J. S. Young, E. T. Mathis, D. R. Tedder, Modeling interindividual variation in physiological factors used in PBPK models of humans, Crit. Rev. Toxicol. 33, 469-503, 2003.
S. Willmann, J. Lippert, M. Sevestre, J. Solodenko, F. Fois, W. Schmitt, PK-Sim, a physiologically based pharmacokinetic whole-body model, Biosilico 1, 121-124, 2003.
Ludbrook G. L., Visco E., Lm A. M., Relation between brain concentrations, electroencephalogram, middle cerebral artery blood flow velocity, and cerebral oxygen extraction during induction of anesthesia, Anesthesiology 2002, 97:1363-70.
Raoof A. A., Van Obbergh L. J., Verbeeck R. K., Propofol pharmacokinetics in children with biliary atresia. Br. J. Anaesth 1995, 74:46-9.
Saint-Maurice C. Cockshott I. D., Douglas E. J., Richard M. O., Harmey J. L., Pharmacokinetics of propofol in young children after a single dose, Br. J. Anaesth 1989, 63(6):667-70.
Valtonen M, Iisalo E., Kanto J., Rosenberg P., Propofol as an induction agent in children, pain on injection and pharmacokinetics. Acta Anaesthesia Sand 1989, 33(2):152-5.
Kanto J., Rosenberg P., Propofol in cesarean section. A pharmacokinetic and pharmacodynamic study, Methods and Findings Experimental Clinical Pharmacology 1990, 12(10)107-11.
Mertens M. J., Olofsen E., Burm A. G., Bovill J. G., Vuyk J., Mixed-effects modeling of the influence of alfentanil on propofol pharmacokinetics, Anesthesiology 2004, 100(4):795-805.
Ickx B., Cockshott I. D., Barvais L., Byttebier G., De P. L., Vandesteene A. et al, Propofol infusion for induction and maintenance of anesthesia in patients with end-stage renal disease, Br. J. Anaesth 1998, 81(6):854-60.
Lysakowski C., Dumont L., Pellegrini M., Clergue F., Tassonyi E., Effects of fentanyl, alfentanil, refentanil and sufentanil on loss of consciousness and bispectral index during propofol induction of anaesthesia. Br. J. Anaesth 2001, 86(4):523-7.
International Search Report dated Sep. 18, 2006.
Edginton Andrea Nicole
Schmitt Walter
Willmann Stefan
Bayer Technology Services GmbH
Berdichevsky Aarti B
Hildebrand, Esq. Christa
Lucchesi Nicholas D
Norris McLaughlin & Marcus P.A.
LandOfFree
Device for the time-controlled intravenous administering of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Device for the time-controlled intravenous administering of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Device for the time-controlled intravenous administering of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4274014